LEADER 03616nam  22006375  450 
001 9910300164203321
005 20200704040757.0
010   $a3-319-12841-8
024 7 $a10.1007/978-3-319-12841-2
035   $a(CKB)3710000000501274
035   $a(EBL)4088773
035   $a(SSID)ssj0001585192
035   $a(PQKBManifestationID)16264904
035   $a(PQKBTitleCode)TC0001585192
035   $a(PQKBWorkID)14866515
035   $a(PQKB)10934903
035   $a(DE-He213)978-3-319-12841-2
035   $a(MiAaPQ)EBC4088773
035   $a(PPN)190531169
035   $a(EXLCZ)993710000000501274
100   $a20151109d2015      u|             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aImaging of Complications and Toxicity following Tumor Therapy$b[electronic resource] /$fedited by Hans-Ulrich Kauczor, Tobias Bäuerle
205   $a1st ed. 2015.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2015.
215   $a1 online resource (308 p.)
225 1 $aDiagnostic Imaging
300   $aDescription based upon print version of record.
311   $a3-319-12840-X 
320   $aIncludes bibliographical references and index.
327   $aPart I: Basics of toxicity of tumor therapies: Chemotherapy and Targeted Therapy -- Radiotherapy -- Part 2: Brain: Radiotherapy -- Chemotherapy -- Part 3: Head and Neck: Head and Neck Therapy -- Part 4 Thorax, Lung and Breast: Breast: focus on Radiotherapy -- Lung: focus on Chemotherapy -- Part 5: Cardiovascular System -- Part 6: Pediatrics: Pediatric Including Survivorship -- Part 7: Pelvis and Genitourinary: Male -- Female -- Part 8. Bone Marrow and Spine: Radiotherapy, special focus myelon -- Chemotherapy -- Part 9 Liver and Gastrointestinal -- Gastrointestinal Vilgrain -- Liver.
330   $aDepending on their mechanism of action, the cytotoxic and targeted drugs and radiotherapy employed in oncologic treatment may cause complications and toxicities in many organ systems, with variable radiologic presentations. This comprehensive and excellently illustrated book covers the basics of therapy-induced complications and toxicities in oncologic patients, identifies their consequences for all the major organs, and describes the imaging of these impacts by means of the various radiologic modalities. By familiarizing radiologists with the most frequent and prominent toxicities that are recognizable on radiologic imaging following tumor therapy, it will facilitate identification of their early manifestations and permit differential diagnosis based on relevant findings.
410  0$aDiagnostic Imaging
606   $aRadiology
606   $aRadiotherapy
606   $aOncology  
606   $aDiagnostic Radiology$3https://scigraph.springernature.com/ontologies/product-market-codes/H29013
606   $aRadiotherapy$3https://scigraph.springernature.com/ontologies/product-market-codes/H29056
606   $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160
615  0$aRadiology.
615  0$aRadiotherapy.
615  0$aOncology  .
615 14$aDiagnostic Radiology.
615 24$aRadiotherapy.
615 24$aOncology.
676   $a616.9940757
702   $aKauczor$b Hans-Ulrich$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aBäuerle$b Tobias$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910300164203321
996   $aImaging of Complications and Toxicity following Tumor Therapy$91866226
997   $aUNINA